UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: November 8, 2011
PEPTIDE TECHNOLOGIES, INC.
----------------------------
(Exact name of registrant as specified in its charter)
Nevada 333-133347 98-0479983
---------------------------- -------------------- ----------------------
(State or other jurisdiction (Commission File (IRS Employer Identifi
of incorporation) Number) -cation Number)
601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
-------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(206) 388-5498
----------------
Registrant's telephone number, including area code
CREEnergy, Inc.
---------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Director
Effective November 8, 2011, Shari Sookarookoff has resigned as a director of
PepTide Technologies, Inc. ("the Company.")
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
Effective on October 12, 2011, the Company filed an amendment to its Articles of
Incorporation with the Secretary of State of Nevada to change its name from
CREEnergy, Inc. to Peptide Technologies, Inc.
As a result of the change, the Company's trading symbol, on the Over the Counter
Market QB board was changed to "PEPT."
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
PEPTIDE TECHNOLOGIES, INC.
By: /s/ Deborah Fortescue-Merrin
------------------------------------
Deborah Fortescue-Merrin, President
Date: November 8, 2011
